Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biotechnology and Pharmaceutical Services Outsourcing Market 

5.1. COVID-19 Landscape: Biotechnology and Pharmaceutical Services Outsourcing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Services

8.1. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services Type, 2023-2032

8.1.1. Consulting

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Auditing and Assessment

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Regulatory Affairs

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Services Outsourcing

9.1. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services Outsourcing, 2023-2032

9.1.1. Pharma

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Biotech

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Biotechnology and Pharmaceutical Services Outsourcing Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Services (2020-2032)

10.1.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Services (2020-2032)

10.1.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Services (2020-2032)

10.1.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Services (2020-2032)

10.2.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Services (2020-2032)

10.2.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Services (2020-2032)

10.2.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Services (2020-2032)

10.2.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Services (2020-2032)

10.2.6.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Services (2020-2032)

10.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Services (2020-2032)

10.3.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Services (2020-2032)

10.3.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Services (2020-2032)

10.3.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Services (2020-2032)

10.3.6.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Services (2020-2032)

10.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Services (2020-2032)

10.4.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Services (2020-2032)

10.4.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Services (2020-2032)

10.4.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Services (2020-2032)

10.4.6.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Services (2020-2032)

10.5.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Services (2020-2032)

10.5.3.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Services (2020-2032)

10.5.4.2. Market Revenue and Forecast, by Services Outsourcing (2020-2032)

Chapter 11. Company Profiles

11.1. ICON Plc

11.1.1. Company Overview

11.1.2. Product Offering

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. The Quantic Group

11.2.1. Company Overview

11.2.2. Product Offering

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Covance Inc.

11.3.1. Company Overview

11.3.2. Product Offering

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. PFA Health Sciences

11.4.1. Company Overview

11.4.2. Product Offering

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. IQVIA Holdings Inc.

11.5.1. Company Overview

11.5.2. Product Offering

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Lachman Consultant Services

11.6.1. Company Overview

11.6.2. Product Offering

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Charles River

11.7.1. Company Overview

11.7.2. Product Offering

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Parexel International Corporation

11.8.1. Company Overview

11.8.2. Product Offering

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. GMP Pharmaceuticals

11.9.1. Company Overview

11.9.2. Product Offering

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Concept Heidelberg GmbH

11.10.1. Company Overview

11.10.2. Product Offering

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms